Skip to content

High death rates in Peruvian patients defaulting from multi-drug-resistant tuberculosis treatment

Scoring tool predicts risk of KS progression

Opt-out testing greatly expanded in new UK HIV testing guidelines, now open for consultation

Malaria returns when Ugandan ART patients stop cotrimoxazole

Roche studies suggest no cancer risk from nelfinavir contamination

Expert views on TB infection control measures

HIV increases risk of nine non-AIDS-defining cancers, largest-ever observational study finds

Shorter TB treatment regimens would provide survival benefit in high HIV-prevalence regions: mathematical model

4 months of rifampicin safer than 9 months of isoniazid for TB prevention